# Phase 4 Hepatitis B trials recruiting: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 4 for Hepatitis B that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Hepatitis B trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/hepatitis-b

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 2, 2026 | NCT07908459 | B-Ensure: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants | GlaxoSmithKline | Phase 4 | Not yet recruiting | Hepatitis B | 303 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908459) |
| September 11, 2026 | NCT07816094 | Comparison of Viral Suppression With 0.5 mg and 1.0 mg Daily Doses of Entecavir in Decompensated HBV Cirrhosis of Liver | Bangladesh Medical University | Phase 4 | Recruiting | Hepatitis B | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816094) |
| May 7, 2026 | NCT07573943 | ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection | The Second Affiliated Hospital of Chongqing Medical University | Phase 4 | Recruiting | Chronic Hepatitis b | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07573943) |
| April 30, 2026 | NCT07560046 | Combating Related Epidemics in HCV | Duke University | Phase 4 | Not yet recruiting | HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV) | 1,280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560046) |
| January 16, 2026 | NCT07345624 | Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Hepatitis B Virus Infection, Children, Chronic Hepatitis B | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07345624) |
| January 16, 2026 | NCT07345611 | Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Hepatitis B Virus Infection, Children, Chronic Hepatitis B | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07345611) |
| December 2, 2025 | NCT07258251 | Strengthening Hepatitis B Screening, Linkage to Care and Long-Term Monitoring in Phichit Province, Thailand: A Birth Bohort Approach | The Task Force for Global Health | Phase 4 | Not yet recruiting | Chronic Hepatitis B, Hepatitis B Virus Infection | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07258251) |
| November 17, 2025 | NCT07231276 | Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B | Nanfang Hospital, Southern Medical University | Phase 4 | Not yet recruiting | HBV, Chronic Hepatitis B Virus | 113 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07231276) |
| September 23, 2025 | NCT07189377 | Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors | University Health Network, Toronto | Phase 4 | Recruiting | Hepatitis B Virus (HBV), Lung Transplant Recipient | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189377) |
| July 17, 2025 | NCT07071636 | Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients | Shenzhen Third People's Hospital | Phase 4 | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Chronic Hepatitis B | 830 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07071636) |
| March 28, 2025 | NCT06900166 | Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low... | Huashan Hospital | Phase 4 | Not yet recruiting | Chronic Hepatitis B | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06900166) |
| January 22, 2025 | NCT06786429 | Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Hepatitis B, Human Papilloma Virus, Mental Health Issue, Cancer Liver, Cancer of Cervix, Depression, Anxiety | 2,140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06786429) |
| April 16, 2024 | NCT06368882 | Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver... | First Affiliated Hospital of Wenzhou Medical University | Phase 4 | Recruiting | Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06368882) |
| April 15, 2024 | NCT06364930 | SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus | Chinese University of Hong Kong | Phase 4 | Recruiting | Chronic Hepatitis B | 412 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06364930) |
| October 16, 2023 | NCT06084234 | National Liver Cancer Screening Trial | University of Texas Southwestern Medical Center | Phase 4 | Recruiting | Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis, Hepatitis B | 5,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06084234) |
| May 11, 2023 | NCT05853718 | Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women | First People's Hospital of Hangzhou | Phase 4 | Recruiting | Chronic Hepatitis b, Tenofovir Alafenamide Fumarate | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05853718) |
| January 10, 2022 | NCT05182463 | Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients | Third Affiliated Hospital, Sun Yat-Sen University | Phase 4 | Recruiting | Hepatitis B, Chronic | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05182463) |
| June 25, 2021 | NCT04939441 | Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF) | Sponsor not shown (see the record) | Phase 4 | Recruiting | Chronic Hepatitis B | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04939441) |
| October 19, 2020 | NCT04588077 | Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis | Mercy Medical Center | Phase 4 | Recruiting | Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04588077) |
| May 1, 2019 | NCT03933384 | Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B | Taichung Veterans General Hospital | Phase 4 | Recruiting | Hepatitis B, Viral Hepatitis | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03933384) |
| January 4, 2019 | NCT03792919 | Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) | Humanity & Health Medical Group Limited | Phase 4 | Recruiting | Chronic Hepatitis B | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03792919) |
| May 20, 2016 | NCT02779465 | Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma | Third Affiliated Hospital, Sun Yat-Sen University | Phase 4 | Not yet recruiting | Hepatitis B, Carcinoma, Hepatocellular | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02779465) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Third Affiliated Hospital, Sun Yat-Sen University | 2 |
| University of Texas Southwestern Medical Center | 1 |
| The Task Force for Global Health | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Mercy Medical Center | 1 |
| The Second Affiliated Hospital of Chongqing Medical University | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| Huashan Hospital | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Bangladesh Medical University | 1 |
| Taichung Veterans General Hospital | 1 |
| First People's Hospital of Hangzhou | 1 |
| University Health Network, Toronto | 1 |
| Shenzhen Third People's Hospital | 1 |
| Humanity & Health Medical Group Limited | 1 |
| Chinese University of Hong Kong | 1 |
| Duke University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 7 |
| United States | 2 |
| Hong Kong | 2 |
| Thailand | 1 |
| Bangladesh | 1 |
| Taiwan | 1 |
| Canada | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Genetics practices in the United States](https://specstream.ai/data/businesses/genetics-practices/united-states)
- [Electrical supply stores in the United States](https://specstream.ai/data/businesses/electrical-supply-stores/united-states)
- [Cleaning products suppliers in the United States](https://specstream.ai/data/businesses/cleaning-products-suppliers/united-states)
- [Bank equipment companies in the United States](https://specstream.ai/data/businesses/bank-equipment-companies/united-states)
- [Aesthetic medicine clinics in the United States](https://specstream.ai/data/businesses/aesthetic-medicine-clinics/united-states)
- [Tiki bars in the United States](https://specstream.ai/data/businesses/tiki-bars/united-states)
